Allion Healthcare, a national provider of specialty pharmacy and disease management services for HIV/AIDS patients, will offer 4 million shares with a price range of $12 to $14 per share. With the price taken at the midpoint ($13), the company would have an initial market cap of $185 million. Thomas Weisel will act as the lead manager on the deal. Timing has yet to be determined.
